Bio-Path Holdings, Inc.
US ˙ OTCPK

Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Gillian C Ivers-read. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Gillian C Ivers-read har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:CLVS / Clovis Oncology Inc See Remarks 293 612
US:BPTH / Bio-Path Holdings, Inc. Director 25 000
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Gillian C Ivers-read. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Internkjøp BPTH / Bio-Path Holdings, Inc. - Analyse av kortsiktig fortjeneste

I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i BPTH / Bio-Path Holdings, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
maks
Pris ved
maks
Maks
fortjeneste ($)
Maks fortjeneste (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

BPTH / Bio-Path Holdings, Inc. Insider Trades
Internhandel BPTH / Bio-Path Holdings, Inc. - Analyse av kortsiktig tap

I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i BPTH / Bio-Path Holdings, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
min
Pris ved
min
Maks tap
unngått ($)
Maks tap
unngått (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

BPTH / Bio-Path Holdings, Inc. Insider Trades
Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Gillian C Ivers-read som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −2 006 293 612 −0,68 0,98 −1 972 288 591
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −1 675 290 993 −0,57 0,98 −1 646 286 017
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4 625 295 618 1,59
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3 749 292 668 1,30
2022-09-06 2022-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −2 234 288 919 −0,77 1,20 −2 681 346 703
2022-09-06 2022-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5 063 291 153 1,77
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −2 100 286 090 −0,73 1,46 −3 068 417 977
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −1 702 283 565 −0,60 1,46 −2 487 414 288
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4 625 288 190 1,63
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3 749 285 267 1,33
2022-06-03 2022-06-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −2 327 281 518 −0,82 0,64 −1 495 180 847
2022-06-03 2022-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5 062 283 845 1,82
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −2 062 278 783 −0,73 1,97 −4 062 549 147
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −1 671 276 220 −0,60 1,97 −3 292 544 098
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −4 625 32 375 −12,50
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −3 749 11 248 −25,00
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4 625 280 845 1,67
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3 749 277 891 1,37
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −10 416 274 142 −3,66 1,87 −19 436 511 549
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −354 264 308 −0,13 1,87 −661 493 199
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 688 0 −100,00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 20 250 60 750 50,00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81 000 81 000
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 20 250 284 558 7,66
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 264 662 0,26
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −2 453 263 974 −0,92 1,94 −4 758 512 057
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −1 989 261 802 −0,75 1,94 −3 858 507 791
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −4 625 37 000 −11,11
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −3 750 14 997 −20,00
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4 625 266 427 1,77
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3 750 263 791 1,44
2021-12-03 2021-12-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −304 260 041 −0,12 3,00 −912 780 123
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −687 688 −49,96
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 260 345 0,26
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −2 041 259 658 −0,78 4,55 −9 287 1 181 444
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −1 655 257 074 −0,64 4,55 −7 530 1 169 687
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −4 625 41 625 −10,00
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −3 749 18 747 −16,67
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4 625 261 699 1,80
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3 749 258 729 1,47
2021-09-03 2021-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −304 254 980 −0,12 4,89 −1 487 1 246 852
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −688 1 375 −33,35
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 255 284 0,27
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −2 034 254 596 −0,79 4,82 −9 804 1 227 153
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −1 649 252 005 −0,65 4,82 −7 948 1 214 664
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −4 625 46 150 −9,11
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −3 749 22 496 −14,28
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4 625 256 630 1,84
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3 749 253 654 1,50
2021-06-03 2021-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −283 249 905 −0,11 5,63 −1 593 1 406 965
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 687 2 063 49,93
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 250 188 0,28
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −2 183 249 501 −0,87 5,54 −12 094 1 382 236
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −1 769 247 059 −0,71 5,54 −9 800 1 368 707
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −4 625 50 875 −8,33
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −3 749 26 245 −12,50
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4 625 251 684 1,87
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3 749 248 828 1,53
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −304 245 079 −0,12 6,29 −1 912 1 541 547
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −276 244 695 −0,11 6,29 −1 736 1 539 132
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 688 2 750 33,37
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 625 0 −100,00
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81 000 81 000
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 245 383 0,28
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 244 971 0,26
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −9 031 244 346 −3,56 7,97 −71 977 1 947 438
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −1 959 234 877 −0,83 7,97 −15 613 1 871 970
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −18 500 55 500 −25,00
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −3 750 29 994 −11,11
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 18 500 253 377 7,88
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3 750 236 836 1,61
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −1 875 0 −100,00
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −829 233 086 −0,35 5,68 −4 709 1 323 928
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1 875 233 915 0,81
2020-12-14 2020-12-10 4 CLVS Clovis Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise −68 965 0 −100,00
2020-12-14 2020-12-10 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes −52 447 232 040 −18,44 4,81 −252 270 1 116 112
2020-12-14 2020-12-10 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 68 965 284 487 32,00 3,28 226 205 933 117
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −687 3 438 −16,65
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −625 625 −50,00
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −304 215 522 −0,14 4,89 −1 487 1 053 903
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 215 826 0,32
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −277 215 139 −0,13 4,89 −1 355 1 052 030
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 215 416 0,29
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −3 749 33 744 −10,00
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −1 689 214 791 −0,78 4,93 −8 327 1 058 920
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3 749 216 480 1,76
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −1 875 1 875 −50,00
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −829 212 731 −0,39 6,85 −5 679 1 457 207
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −9 213 560 0,00 6,86 −62 1 465 022
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1 875 213 569 0,89
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −688 4 125 −14,29
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −625 1 250 −33,33
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −290 211 694 −0,14 5,30 −1 537 1 121 978
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 211 984 0,33
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −263 211 296 −0,12 5,30 −1 394 1 119 869
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 211 559 0,30
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −3 749 37 493 −9,09
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −1 670 210 934 −0,79 5,92 −9 886 1 248 729
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3 749 212 604 1,80
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −1 875 3 750 −33,33
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −829 208 855 −0,40 6,74 −5 587 1 407 683
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1 875 209 684 0,90
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −687 4 813 −12,49
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −625 1 875 −25,00
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −313 207 809 −0,15 7,03 −2 200 1 460 897
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 208 122 0,33
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −285 207 435 −0,14 7,03 −2 004 1 458 268
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 207 720 0,30
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −3 749 41 242 −8,33
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −1 475 207 095 −0,71 8,10 −11 948 1 677 470
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3 749 208 570 1,83
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −1 875 5 625 −25,00
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −829 204 821 −0,40 4,60 −3 813 942 177
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1 875 205 650 0,92
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −688 5 500 −11,12
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −625 2 500 −20,00
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −317 203 775 −0,16 7,20 −2 282 1 467 180
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 204 092 0,34
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −288 203 404 −0,14 7,20 −2 074 1 464 509
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 203 692 0,31
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −14 997 44 991 −25,00
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −7 204 203 067 −3,43 8,41 −60 586 1 707 793
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 14 997 210 271 7,68
2020-01-31 2020-01-31 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 74 000 74 000
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −1 875 7 500 −20,00
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −830 195 274 −0,42 11,30 −9 379 2 206 596
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1 875 196 104 0,97
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −687 6 188 −9,99
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −625 3 125 −16,67
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −310 194 229 −0,16 14,59 −4 523 2 833 801
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 194 539 0,35
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −282 193 852 −0,15 14,60 −4 117 2 830 239
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 194 134 0,32
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −1 875 9 375 −16,67
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −837 193 509 −0,43 4,80 −4 018 928 843
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1 875 194 346 0,97
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −688 6 875 −9,10
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −625 3 750 −14,29
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −330 192 471 −0,17 5,21 −1 719 1 002 774
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 192 801 0,36
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −300 192 113 −0,16 5,21 −1 563 1 000 909
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 192 413 0,33
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −1 875 11 250 −14,29
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −829 191 788 −0,43 14,70 −12 186 2 819 284
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1 875 192 617 0,98
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −687 7 563 −8,33
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −625 4 375 −12,50
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −302 190 742 −0,16 15,07 −4 551 2 874 482
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 191 044 0,36
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −275 190 357 −0,14 15,07 −4 144 2 868 680
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 190 632 0,33
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −1 875 13 125 −12,50
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −830 190 007 −0,43 26,13 −21 688 4 964 883
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1 875 190 837 0,99
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −2 750 8 250 −25,00
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −625 5 000 −11,11
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −1 295 188 962 −0,68 29,29 −37 931 5 534 697
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2 750 190 257 1,47
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −316 187 507 −0,17 29,29 −9 256 5 492 080
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 187 823 0,33
2019-02-04 2019-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 59 988 59 988
2019-02-04 2019-02-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 19 996 19 996
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −1 875 15 000 −11,11
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −829 187 198 −0,44 17,72 −14 690 3 317 149
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1 875 188 027 1,01
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −625 5 625 −10,00
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −250 186 152 −0,13 21,23 −5 308 3 952 007
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 186 402 0,34
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −1 875 16 875 −10,00
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes −829 185 777 −0,44 32,21 −26 702 5 983 877
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1 875 186 606 1,01
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −625 6 250 −9,09
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes −282 184 731 −0,15 35,75 −10 082 6 604 133
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 185 013 0,34
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −1 875 18 750 −9,09
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes −829 184 388 −0,45 45,75 −37 927 8 435 751
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1 875 185 217 1,02
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −625 6 875 −8,33
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes −278 183 342 −0,15 47,70 −13 261 8 745 413
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 183 620 0,34
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −1 875 20 625 −8,33
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes −829 182 995 −0,45 56,75 −47 046 10 384 966
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1 875 183 824 1,03
2018-03-07 2018-03-06 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −2 500 7 500 −25,00
2018-03-07 2018-03-06 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes −1 122 181 949 −0,61 58,43 −65 558 10 631 280
2018-03-07 2018-03-06 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2 500 183 071 1,38
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 11 000 11 000
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 11 000 11 000
2018-02-16 2018-02-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −3 000 180 571 −1,63 54,09 −162 270 9 767 085
2018-01-17 2018-01-16 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −3 000 183 571 −1,61 59,16 −177 480 10 860 060
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise −7 500 22 500 −25,00
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes −3 512 186 571 −1,85 63,80 −224 066 11 903 230
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 7 500 190 083 4,11
2017-12-18 2017-12-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −3 000 182 583 −1,62 64,16 −192 480 11 714 525
2017-11-16 2017-11-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −3 000 185 583 −1,59 63,70 −191 100 11 821 637
2017-10-17 2017-10-16 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −3 000 188 583 −1,57 84,54 −253 620 15 942 807
2017-09-18 2017-09-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −3 000 191 583 −1,54 69,50 −208 500 13 315 018
2017-08-15 2017-08-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −3 000 194 583 −1,52 70,05 −210 150 13 630 539
2017-07-17 2017-07-17 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −3 000 197 583 −1,50 91,56 −274 680 18 090 699
2017-06-15 2017-06-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −3 000 200 583 −1,47 61,82 −185 460 12 400 041
2017-05-15 2017-05-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −3 000 203 583 −1,45 47,39 −142 170 9 647 798
2017-04-17 2017-04-17 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −3 000 206 583 −1,43 56,02 −168 060 11 572 780
2017-03-28 2017-03-27 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 10 000 10 000
2017-03-28 2017-03-27 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 20 000 20 000
2017-03-15 2017-03-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −3 000 209 583 −1,41 66,99 −200 970 14 039 965
2016-12-19 2016-12-19 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 30 000 30 000
2016-09-19 2016-09-16 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
J - Other −8 750 26 250 −25,00
2015-10-16 2015-10-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −3 000 212 583 −1,39 91,91 −275 730 19 538 504
2015-09-22 2015-09-18 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale −3 000 215 583 −1,37 112,56 −337 680 24 266 022
2015-03-04 2015-03-02 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 35 000 35 000
2014-04-28 2014-04-25 4 BPTH BIO-PATH HOLDINGS INC
Stock Option
A - Award 25 000 25 000
2014-01-14 2014-01-10 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 70 000 70 000
2013-04-26 2013-04-25 4 BPTH BIO-PATH HOLDINGS INC
Stock Option
A - Award 25 000 25 000
2013-03-04 2013-03-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 75 000 75 000
2013-02-21 2013-02-19 4 BPTH BIO-PATH HOLDINGS INC
Stock Option
A - Award 25 000 25 000
2012-03-05 2012-03-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 50 000 50 000
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)